%0 Journal Article
%T Will Sofosbuvir/Ledipasvir (Harvoni) Be Cost-Effective and Affordable for Chinese Patients Infected with Hepatitis C Virus? An Economic Analysis Using Real-World Data
%A April Wong
%A Bing Li
%A Cheng Wang
%A Dong Ji
%A Fan Li
%A George Lau
%A Gui-Qiang Wang
%A Guo-Feng Chen
%A Hong Ren
%A Hui Zhuang
%A Ji-Dong Jia
%A Jia Shang
%A Jia-Liang Liu
%A Jian-Gao Fan
%A Jin-Lin Hou
%A Jing Chen
%A Jiu-Ping Wang
%A Jun Cheng
%A Lai Wei
%A Lun-Gen Lu
%A Ning Du
%A Qing Shao
%A Qing Xie
%A Qing-Chun Fu
%A Vanessa Wu
%A Wen-Hong Zhang
%A Xiao-Guang Dou
%A Xiao-Jin Wang
%A Xiao-Xia Niu
%A Xing-Xiang Yang
%A Ying Han
%A Yu-Dong Wang
%A Yue-Xin Zhang
%A Zhan-Sheng Jia
%A Zhong-Ping Duan
%J Archive of "PLoS ONE".
%D 2016
%R 10.1371/journal.pone.0155934
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898683/